Intakes of dietary fibre or its components have been (inversely) related to the prevalence of several diseases of the intestinal tract, including cancer, and to ischaemic heart disease, obesity, and diabetes. Recent reports on diet and health have accepted that benefit is likely to accrue from an increased intake of dietary fibre, particularly cereal fibre. Only the most recent of these reports has attempted to quantify the amount needed: it recommends that the average intake in Britain and 1976, however, and starch was removed by digestion with takadiastase, which was likely to have been contaminated with enzymes also capable of digesting part of the cellulose and hemicelluloses. As consumption of brown and wholemeal bread, which contains more fibre, has also increased substantially in Britain since 1976, there is a clear need for new and accurate information on the amounts of dietary fibre in foods and of its constituent fractions.
New fractionation technique
When the Ministry of Agriculture, Fisheries, and Food assumed sole responsibility for revising the British food compositioti tables 'he first foods to be analysed included 103 types of bread and other cereal 4products and 35 meat products which contain cereals. The method for measuring fibre was still based on the original fractionation technique of Southgate,4 but it had been improved in that a mixture of amyloglucosidase and cc-amylase was used to break down starch; this was followed by digestion with hot 5% sulphuric acid for one hour and then with 72% sulphuric acid overnight at 40C. Sugars and uronic acids in these hydrolysates were measured colorimetrically, and the final residue (lignin) was weighed. Dietary fibre was taken as the sum of the lignin, cellulose, and non-cellulosic polysaccharides weighed during this fractionation method.
The most important consequences of the modifications of the fractionation technique were that more pentose and hexose non-cellulosic polysaccharides were found and a greater residue of lignin remained. For example, sliced white bread now appears to contain 4-1 g fibre/100 g compared with the previous estimate of 2-7 g/100 g.3 This report measures the effects of the new analyses on the average intake of dietary fibre and the major components of this fibre in the diet of the nation as a whole. (Full details of the methods used and of the fibre contents of individual foods will be published elsewhere.) that would have been recorded using earlier analyses.3 4Both amounts are based on the consumption of food recorded in the National Food Survey of 1982. The main effects are that the total intake is now 22-2 g and not 19-8 g/person/day, which may be compared with the recent recommendation for an increase to 25 g/person/day by 1990,1 and that the epidemiiologically important pentose fraction of the non-cellulosic polysaccharides and the intake of lignin have increased by 52% and 70%, respectively. Despite the continued decline in the consumption of white bread, the contribution of the nutritionally important cereal fibre to the total has also risen by 28%O. 
Patients, methods, and results
We studied 28 children (18 boys, 10 girls) aged 3-13 presenting to the accident and emergency department of this centre with acute asthma. All parents gave informed consent. Children who had received bronchodilator treatment with an aerosol within two hours before presentation were excluded.
The children were randomly allocated to two groups receiving 1 % terbutaline sulphate either through a Hudson nebuliser attached to an air cylinder (flow rate 6 1/minute) or by metered dose aerosol through a Nebuhaler. The nebuliser solution was made up to 2 ml with saline and nebulised completely. Doses were based on weight4: children weighing under 20 kg received 0-25 ml (2-5 mg) through a nebuliser or five puffs (1.25 mg) through a Nebuhaler; those weighing over 20 kg received 0-5 ml (5 mg) through a nebuliser or 10 puffs (2-5 mg) through a Nebuhaler. The Nebuhaler was used for one minute to ensure complete intake of the dose.
All patients were evaluated clinically at 0, 15, and 30 minutes after receiving terbutaline by MF, who measured clinical variables useful in assessing the severity of asthma5-namely, dyspnoea, wheeze, muscle contraction, supraclavicular excavation, thoracoabdominal paradox, pulse, respiratory rate, and pulsus paradoxus. Variables were assessed on a scale of 0-4 and a total score obtained. Peak expiratory flow rate was measured with Wright's mini peak flow meter in children able to cooperate (six in the nebuliser and 11 in the Nebuhaler groups). The best of three attempts was recorded and expressed as a percentage of the value predicted for sex and height.
Results were analysed using Wilcoxon's signed rank test and paired or unpaired t tests when appropriate.
The sex distribution in the two groups were the same, but mean ages were 6-1 years in the nebuliser and 9-1 years in the Nebuhaler group (p < 0 005). The figure shows the mean clinical scores and peak expiratory flow rates. There were no significant differences between the groups at any time but both groups showed appreciable improvements at 15 and 30 minutes. Time (rmnutes) Mean (SE) clinical scores and peak expiratory flow rates in groups using a nebuliser and Nebuhaler. There was a significant reduction in clinical scores (*p < 0-01) and improvement in peak expiratory flow rates (*p<0-01, **p<0.02) in both groups but no significant differences between groups.
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One child from the Nebuhaler group and three from the nebuliser group required admission to hospital despite initial treatment. Four children who used the Nebuhaler, including the one admitted, had difficulty triggering the valve, which was related to a greater degree of airways obstruction. On the other hand, four patients who had repeatedly used aerosols at home with little improvement responded well to the Nebuhaler.
Comment
The results indicate that in children with acute asthma equal bronchodilatation can be achieved with Nebuhalers and nebulisers. Younger children and patients with severe airways obstruction, however, had problems with the Nebuhaler, probably because they could not produce sufficient flow rates to trigger the valve. The manufacturers are now investigating this. We conclude that, apart from this limitation, the Nebuhaler is an acceptable and cheaper alternative to wet nebuliser treatment of acute asthma in childhood.
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